
0.10 Delayed Data As of Mar 28 | ![]() Today’s Change | 0.04 Today|||52-Week Range 3.25 | +89.57% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $13.5M |
Clovis Oncology, Inc. 5500 Flatiron Parkway Boulder Colorado 80301 |
Patrick J. Mahaffy | President, Chief Executive Officer & Director |
Daniel W. Muehl | Chief Financial Officer & Executive Vice President |
Lindsey Rolfe | Chief Medical Officer & Executive VP-Clinical |
Thomas Fuglsang Harding | Chief Scientific Officer & Executive VP |
Paul Edward Gross | Secretary, Executive VP & General Counsel |